Giacomel A, Martins D, Nordio G, Easmin R, Howes O, Selvaggi P
Mol Psychiatry. 2025; .
PMID: 40021831
DOI: 10.1038/s41380-025-02938-w.
Leitzke M, Roach D, Hesse S, Schonknecht P, Becker G, Rullmann M
Bioelectron Med. 2025; 11(1):5.
PMID: 40011942
PMC: 11866872.
DOI: 10.1186/s42234-025-00167-8.
Salarian M, Liu S, Tsai H, Leslie S, Hayes T, Lo S
Mol Imaging Biol. 2025; .
PMID: 40009327
DOI: 10.1007/s11307-025-01991-9.
Saarinen A, Tuominen L, Puttonen S, Raitakari O, Keltikangas-Jarvinen L, Hietala J
Neuropsychopharmacology. 2025; .
PMID: 39890998
DOI: 10.1038/s41386-025-02059-6.
Gu J, Zheng M, Holden D, Fowles K, Qiu L, Felchner Z
Mol Imaging Biol. 2025; 27(1):54-63.
PMID: 39779653
DOI: 10.1007/s11307-024-01979-x.
A Reference Tissue Implementation of Simultaneous Multifactor Bayesian Analysis (SiMBA) of PET Time Activity Curve Data.
Matheson G, Lundberg J, Garde M, Veldman E, Tateno A, Okubo Y
bioRxiv. 2024; .
PMID: 39677746
PMC: 11642925.
DOI: 10.1101/2024.12.04.626559.
Exploration of (R)-[C]YH168 as a PET tracer for imaging monoacylglycerol lipase in the brain: from mice to non-human primates.
He Y, Zheng M, Gu J, Reichert L, Trimborn J, Zhang H
Eur J Nucl Med Mol Imaging. 2024; 52(4):1556-1565.
PMID: 39673602
PMC: 11839854.
DOI: 10.1007/s00259-024-07013-0.
Central dopamine receptors: Radiotracers unveiling the Role of dopaminergic tone in obesity.
Pais M, Crisostomo J, Abrunhosa A, Castelo-Branco M
J Mol Med (Berl). 2024; 103(1):21-32.
PMID: 39630278
PMC: 11739276.
DOI: 10.1007/s00109-024-02501-0.
Intra-striatal dopaminergic inter-subject covariance in social drinkers and non-treatment-seeking alcohol use disorder participants.
Chumin E, Dzemidzic M, Yoder K
Addict Biol. 2024; 29(11):e70008.
PMID: 39576234
PMC: 11583815.
DOI: 10.1111/adb.70008.
Numerical simulation method for the assessment of the effect of molar activity on the pharmacokinetics of radioligands in small animals.
Kikuchi T, Okamura T, Zhang M
EJNMMI Radiopharm Chem. 2024; 9(1):78.
PMID: 39570519
PMC: 11582259.
DOI: 10.1186/s41181-024-00308-5.
"Neuroinflammation": does it have a role in chronic pain? Evidence from human imaging.
Loggia M
Pain. 2024; 165(11S):S58-S67.
PMID: 39560416
PMC: 11729497.
DOI: 10.1097/j.pain.0000000000003342.
Endogenous opioid receptor system mediates costly altruism in the human brain.
Chen J, Putkinen V, Seppala K, Hirvonen J, Ioumpa K, Gazzola V
Commun Biol. 2024; 7(1):1401.
PMID: 39462097
PMC: 11513155.
DOI: 10.1038/s42003-024-07084-7.
Modeling PET Data Acquired During Nonsteady Conditions: What If Brain Conditions Change During the Scan?.
Morris E, Emvalomenos G, Hoye J, Meikle S
J Nucl Med. 2024; 65(12):1824-1837.
PMID: 39448268
PMC: 11619587.
DOI: 10.2967/jnumed.124.267494.
PET Mapping of Receptor Occupancy Using Joint Direct Parametric Reconstruction.
Marin T, Belov V, Chemli Y, Ouyang J, Najmaoui Y, El Fakhri G
IEEE Trans Biomed Eng. 2024; 72(3):1057-1066.
PMID: 39446540
PMC: 11875991.
DOI: 10.1109/TBME.2024.3486191.
Characterization of patients with major psychiatric disorders with AMPA receptor positron emission tomography.
Hatano M, Nakajima W, Tani H, Uchida H, Miyazaki T, Arisawa T
Mol Psychiatry. 2024; .
PMID: 39406998
DOI: 10.1038/s41380-024-02785-1.
Imaging the translocator protein 18 kDa within cognitive control and declarative memory circuits in virally suppressed people with HIV.
Rubin L, Maki P, Du Y, Sweeney S, OToole R, Nam H
AIDS. 2024; 39(2):133-142.
PMID: 39405127
PMC: 11717590.
DOI: 10.1097/QAD.0000000000004034.
Advances and challenges in immunoPET methodology.
Mohr P, van Sluis J, Lub-de Hooge M, Lammertsma A, Brouwers A, Tsoumpas C
Front Nucl Med. 2024; 4:1360710.
PMID: 39355220
PMC: 11440922.
DOI: 10.3389/fnume.2024.1360710.
The Application of Methods for Prediction of Blood-Brain Barrier Permeability of Small Molecule PET Tracers.
Steen E, Vugts D, Windhorst A
Front Nucl Med. 2024; 2:853475.
PMID: 39354992
PMC: 11440968.
DOI: 10.3389/fnume.2022.853475.
Improved Quantification of MicroPET/CT Imaging Using CT-derived Scaling Factors.
Nandi A, Nakano M, Brasic J, Brinson Z, Kitzmiller K, Mathur A
Mol Imaging Biol. 2024; 26(6):1016-1026.
PMID: 39313673
DOI: 10.1007/s11307-024-01947-5.
Kappa opioid receptor availability predicts severity of anhedonia in schizophrenia.
Slifstein M, Qu W, Gil R, Weinstein J, Perlman G, Jaworski-Calara T
Neuropsychopharmacology. 2024; 49(13):2087-2093.
PMID: 39217267
PMC: 11480413.
DOI: 10.1038/s41386-024-01975-3.
